Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- 6 Easy Lifestyle Changes That May Help Prevent Alzheimer’s Disease
- Improving access to medicines for patients with reduced hand function
- How to Increase Mental
- Unexpected GLP-1 side effect? Studies show the meds may help people with addictions
- ASH Volleyball shares gym with rival Pineville during asbestos cleanup
- Redeemed Nutrition marks seven years serving Plainview
- UVA Researchers Help Develop NATO Brain Health Guidelines
- Small Needle, Big Questions: GLP
Browsing: Wellness Tips
The U.S. obesity rate dropped as use of GLP-1 weight loss drugs surged.A Gallup survey finds the use of GLP-1 weight loss drugs at a new high even as the U.S. obesity rate shows a ‘meaningful’ decline. (U.S. News and World Report)
The cross-border network distributed more than 200,000 counterfeit condoms across the continent
According to my smart phone I walk about 8200 steps, or about four miles, every day when I’m on the golf course. That translates to about four miles. According to my phone’s health app, I burned only 191 calories. To celebrate, I ate a candy bar containing 250 calories. You’ve all done the same; admit…
1 medications are best known for their use in obesity and diabetes treatment, but new research suggests they may have potential in cancer prevention
Is It Too Late to Buy Eli Lilly Stock? Here’s What $1,000 Invested Today Could Be Worth in 10 Years.
Obesity drugs might be the hottest growth story in healthcare right now. GLP-1 agonists and similar drugs encourage weight loss for managing obesity and treating type 2 diabetes. The viral success of Mounjaro and Zepbound has made Eli Lilly (NYSE: LLY) a home run winner. The stock’s 160% run over the past three years has…
– ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting three validated targets of amylin receptor, GLP-1R and GIPR
Our city is full of exciting people, places and businesses! H-Town Spotlight is a fun and informative segment that showcases all that Houston has to offer!
The comedian and actor, who celebrated his milestone 60th birthday on July 7, has lost 50 pounds since going on the GLP-1 drug Mounjaro in 2023
Demand for GLP-1 weight loss drugs has reshaped the healthcare industry. And ETFs such as the Amplify Weight Loss Drug & Treatment ETF (THNRB-) give investors a way to access this growing market. What was once a small corner of the pharmaceutical market is now expected to become a $130 billion to $150 billion market…
(HealthDay News) — Obesity accounts for a considerable amount of cases of polypharmacy among older adults, according to a study published online June 4 in the Journal of General Internal Medicine

